These results illustrate that the hyperactive NF-κB signalling in GBM promotes the expression of miR-148a oncogene, which further promotes the aggressive phenotypes of GBM by downregulating the expression of QKI and SKP1 and activating the TGF-β signalling [82]. This evidence concerns the gene NFKB1 and glioblastoma.